Inspire Medical Systems, Inc. Announces Events at International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings
26 Septiembre 2023 - 7:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical
technology company focused on the development and commercialization
of innovative, minimally invasive solutions for patients with
obstructive sleep apnea, announced today key events at the
International Surgical Sleep Society (ISSS) and American Academy of
Otolaryngology (AAO-HNSF) meetings in Nashville, TN, September 29
through October 4.
“We look forward to participating in ISSS and AAO-HNSF to
highlight our Inspire technology platform and share clinical data
demonstrating the real-world efficacy of our therapy,” said Tim
Herbert, President and CEO. “Inspire is a proud partner and sponsor
of ISSS, the world’s preeminent organization dedicated to the
surgical evaluation and treatment of patients with sleep disorders,
and AAO-HNSF, one of the world's largest organizations representing
ENTs.”
At the Inspire booth, physicians can review the Inspire
procedure using 3D visualization software and receive updates on
technology enhancements including the Inspire SleepSync™ remote
patient management platform.
In the scientific sessions, Inspire will be featured throughout
the meetings in panel discussions, oral abstracts, and posters
presented by leading otolaryngologists and sleep surgeons.
Selected ISSS Research Oral
Presentations (September 29, 3:30-5:00 pm CT, Meadow
Ballroom C)
- Preliminary analysis from the PREDICTOR study (NCT05428839) to
assess office-based diagnostic predictors of Drug-Induced Sleep
Endoscopy (DISE) in patients with obstructive sleep apnea. Jordan
Weiner, MD
- ADHERE registry update analyzing BMI changes after implant.
Chihun Han, MD
AAO Events
- Inspire OTO Pavilion Presentation, Transform OSA Outcomes:
Expert Guidance for Adding Inspire Therapy to Your Practice
featuring Dr. Glenn Rothman and Dr. Leela Lavasani Sunday, October
1, 12:00 to 1:00 pm CT, booth 2228
- Inspire Investor Booth Tour at AAO-HNSF Sunday, October 1, 3:30
to 4:30 pm CT, booth 712
- Inspire Cocktail Reception Sunday, October 1, 6:00 to 8:00 pm
CT, L27 at the Westin
Selected AAO Presentations of Interest
- Hypoglossal nerve stimulation in Down syndrome children:
secondary outcomes analyses. Miller Anderson Richmond, BS. October
1, 1:00 pm CT in MCC 207CD
- ADHERE registry update: Relationship of insomnia symptoms and
outcomes after hypoglossal nerve stimulation. James S Coxe, MD.
October 3, 9:15 am CT in MCC 103A
About ISSSThe ISSS is the world’s preeminent
organization dedicated to the surgical evaluation and treatment of
patients with sleep disorders. For more information, please visit
www.surgicalsleep.org.
About AAO-HNSFThe AAO-HNS (“the Academy”) is
one of the world's largest organizations representing specialists
who treat the ear, nose, throat, and related structures of the head
and neck. Head and neck surgeons diagnose and treat medical
disorders that are among the most common affecting patients of all
ages in the United States and around the world. Those medical
conditions include chronic ear disease, hearing and balance
disorders, hearing loss, sinusitis, snoring and sleep apnea,
allergies, swallowing disorders, nosebleeds, hoarseness, dizziness,
and tumors of the head and neck as well as intricate micro-surgical
procedures of the head and neck. The Academy represents
approximately 13,000 ENT surgeons. For more information, please
visit www.entnet.org.
About Inspire Medical SystemsInspire is a
medical technology company focused on the development and
commercialization of innovative, minimally invasive solutions for
patients with obstructive sleep apnea. Inspire’s proprietary
Inspire therapy is the first and only FDA-approved neurostimulation
technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit
www.inspiresleep.com.
Forward Looking Statements
This press release may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements involve inherent risks and
uncertainties, and important factors could cause actual results to
differ materially from those anticipated, including the factors
identified under the captions “Risk Factors” and “Management's
Discussion and Analysis of Financial Condition and Results of
Operations” in our Annual Report on Form 10-K for the fiscal year
ended December 31, 2022 filed with the SEC, and as such factors may
be updated from time to time in our other filings with the SEC,
which are accessible on the SEC’s website at www.sec.gov and the
Investors page of our website at www.inspiresleep.com.
Forward-looking statements speak only as of the date they are made,
and we undertake no obligation to update them in light of new
information or future events.
Investor and Media Contact:Ezgi YagciVice
President, Investor Relationsezgiyagci@inspiresleep.com
617-549-2443
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024